pharmacie et médicaments – Prise en charge de la technologie "boucle fermée" pour le traitement du diabète

This written question concerns the coverage of closed-loop technology for diabetes treatment. It seeks clarification on how this innovative technology will be integrated into healthcare systems. The question addresses patients with diabetes, healthcare providers, and pharmaceutical companies involved in diabetes management technologies.